Recent Advances in Synthetic Bioelastomers by Shi, Rui et al.
Int. J. Mol. Sci. 2009, 10, 4223-4256; doi:10.3390/ijms10104223 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Review 
Recent Advances in Synthetic Bioelastomers 
Rui Shi 
1, Dafu Chen 
1, Quanyong Liu 
2, Yan
 Wu 
2, Xiaochuan Xu 
3, Liqun Zhang 
2,* and 
Wei Tian 
1,3,* 
1  Laboratory of Bone Tissue Engineering of Beijing Research Institute of Traumatology and 
Orthopaedics, Beijing 100035, China; E-Mails: sharell@126.com (R.S.); 
chendafugo@yahoo.com.cn (D.C.) 
2  Beijing Key Laboratory on Preparation and Processing of Novel Polymer Materials at Beijing 
University of Chemical Technology, 100029, China; E-Mails: liu_quanyong@126.com (Q.L.); 
wuyan412@126.com (Y.W.) 
3  Department of Spine Surgery of Beijing JiShuiTan Hospital, the Fourth Clinical Medical College of 
Peking University, Beijing 100035, China; E-Mails: xxcwyw@hotmail.com (X.X.) 
*  Authors to whom correspondence should be addressed; E-Mails: zhanglq@mail.buct.edu.cn (L.Z.); 
tianweia@163bj.com (W.T.); Tel.: +86-010-64421186 (L.Z.); +86-010-58516385 (W.T.);   
Fax: +86-010-64433964 (L.Z.); +86-010-58516538 (W.T.). 
Received: 4 August 2009; in revised form: 30 August 2009 / Accepted: 8 September 2009 /  
Published: 29 September 2009 
 
 
Abstract: This article reviews the degradability of chemically synthesized bioelastomers, 
mainly designed for soft tissue repair. These bioelastomers involve biodegradable 
polyurethanes, polyphosphazenes, linear and crosslinked poly(ether/ester)s, 
poly(ε-caprolactone) copolymers, poly(1,3-trimethylene carbonate) and their copolymers, 
poly(polyol sebacate)s, poly(diol-citrates) and poly(ester amide)s. The in vitro and in vivo 
degradation mechanisms and impact factors influencing degradation behaviors are 
discussed. In addition, the molecular designs, synthesis methods, structure properties, 
mechanical properties, biocompatibility and potential applications of these bioelastomers 
were also presented.   
Keywords: bioelastomer; biodegradable; biocompatible; polyurethanes; polyphosphazenes; 
poly(ether ester); poly(ε-caprolactone); poly(1,3-trimethylene carbonate); poly(polyol 
sebacate)s; poly(diol-citrates); poly(ester amide)s 
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1. Introduction 
 
On the basis of the ASTM definition of ‘elastomer’, as well as the specific biological setting where 
bioelastomers are used, the ‘bioelastomer’ can be described as a substance with the following 
characteristics: good biocompatibility with neighboring/surrounding tissues; a glass transition 
temperatures (Tg) lower than body temperature (35–40 °C); the ability to return to at least 1.25-fold 
the original length after 1 min of release if stretched to 1.5-fold its original length for 1 min, 
maintaining the stretch stress in the range of 0.1–20 MPa. These biomaterials can be applied in the 
clinical fields of diagnosis, treatment, tissue repair or replacement, as well as tissue function 
enhancement.  
The use of elastomers for biomedical applications goes back to the time when the rubber industry 
started. At that time, vulcanized natural rubber was used in medical devices. The commodity 
elastomers which happened to be used in biomedical fields and medical grades of elastomers certified 
for short-term physiological contact are not covered in this review.   
Generally speaking, bioelastomers can be classified in two categories: 1) the elastomers suitable for 
long term physiological contact or implantation; 2) biodegradable elastomers for a determined time of 
physiological contact or implantation. With the development of tissue engineering, biodegradable 
elastomers have shown their strong advantages in clinical applications. As many tissues in the body 
have elastomeric properties, successful repair or replacement of these tissues will require the 
development of compliant biodegradable elastomeric scaffolds that can sustain and recover from 
multiple deformations without irritation to the surrounding tissue [1].   
According to the product source, biodegradable elastomers can be classified into three categories: 1) 
naturally extracted and/or biosynthetic bioelastomers; protein- and/or peptide-based elastomers are 
included in this kind; 2) biosynthetic degradable polyesters; polyhydroxyalkanoates (PHAs) are the 
most important ones in this kind; 3) chemically synthesized biodegradable elastomers; these are what 
this review is about. For the natural (protein- and /or peptide-based) [2–4] and biosynthetic (PHAs) 
[5–11] readers are referred to the works by other researchers. 
 
2. Requirements of Degradable Bioelastomers 
 
In general, all biomedical elastomers must be of high purity, offer good processing performance, 
and optimal physical, chemical and mechanical properties. When they are implanted in the human 
body, adverse events such as thrombosis, cell injuries, plasma and protein degeneration, enzyme 
inactivation, electrolytes disturbances/imbalances, inflammation, carcinogenesis, intoxication and 
allergic reactions should not occur [12]. For biodegradable elastomers, the rate of degradation is one of 
the most important properties. For example, as a tissue engineering scaffold, the rate of the degradation   
should match that of tissue regeneration, with the material being completely degraded so as not to 
leave any reminding particles that may cause irritation or inflammation.   
All biodegradable polymers contain hydrolysable bonds. For this reason, the most important 
mechanism of degradation for tissue engineering scaffolds is chemical degradation through hydrolysis 
or enzyme-catalyzed hydrolysis. To a lesser extent, oxidation can also be a degradation mechanism.   Int. J. Mol. Sci. 2009, 10                 
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For most bioelastomers, passive hydrolysis is the dominant mechanism of degradation. There are 
several factors that influence the polymer biodegradability, including the type of chemical bond, 
polymer crystallinity, hydrophilicity, composition, pH value and temperature. 
The type of chemical bond determines the rate of hydrolysis [8]. In general, anhydrides and 
orthoesters are the most hydrolysable, followed by esters and amides [13]. However, it should be noted 
that the rate of hydrolysis is greatly affected by catalysis. Hydrolysis can be thought of as a reaction 
between water and the labile bond. Consequently, the degradation rates for hydrophilic polymers are 
much greater than hydrophobic ones due to the ease of water absorbtion [8]. 
The most commonly parameter which is used to determine the degradation rate is the time 
dependent molecular weight. The polymer can be placed in an aqueous medium. Enzymes are always 
added to mimic the biological environment. In addition to molecular weight change, degradation may 
be assessed through mechanical property changes, weight loss, surface porosity, surface hydrophilicity 
(judged by contact angle), monomer or oligomer formation, or changes in pH value of the aqueous 
medium. Most of the time, a thorough understanding of the degradation mechanism should be obtained 
from all characteristics as a result of the sensitivities of these methods differ widely. For example, the 
mechanical properties can decrease dramatically even when the weight loss didn’t change so much.   
The degradation procedure can be classified as surface degradation and bulk degradation [14]. The 
rate of the surface degradation should be easily predictable, because the degradation happened from 
the surface of the polymer, and the shape of the polymer is often kept well. This is particularly 
desirable for drug delivery applications, where the rate of drug release from the polymer can be 
directly related to the rate of degradation. The mechanical properties always have a linear relationship 
with degradation time. When bulk degradation happens, the weight is lost throughout the sample, but 
the original size of the samples could be kept for a long time. The bulk degradation maybe helpful to 
the drug bust release, and sometimes, tissue engineering scaffold.   
The degradation rate can be measured in vitro and in vivo. For an accurate measurement, the in vivo 
degradation was often applied. The materials were implanted in the model animals. The changes of the 
biomaterial at the determine time interval was observed by X-ray diffraction, histological sections, etc. 
 
3. Synthetic Bioelastomers   
 
The types of biodegradable polymer, glass transition temperature, mechanical properties, 
approximate degradation time and the degradation products are summarized in Table 1. 
Table 1. Synthetic biodegradable bioelastomers. 
Synthetic 
Bioelastomers 
Tg (°C) 
TS 
(MPa) 
EB(%) 
Approx 
DT 
Degradation Products  Referrences 
PUs  −116 –
−41 
4–60 100–950 wide  time 
range 
α-hydroxy acids, 
urethane, urea 
fragments, lysine (for 
lysine-derived 
polyisocyanates) 
[15] 
[16] 
PNs  −105 –
91 
Wide 
range 
Wide 
range 
wide time 
range 
phosphate, 
ammonium salts, amino 
acids, and ethanol 
[17] 
[18] Int. J. Mol. Sci. 2009, 10                 
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Table 1. Cont. 
Synthetic 
Bioelastomers 
Tg (°C) 
TS 
(MPa) 
EB(%) 
Approx 
DT 
Degradation Products  Referrences 
            
PGS
a 
 
−7–46 >0.5  >267  1  Glycerol,  sebacate  [19,20] 
POC
b  −5–10  Up to 6.7  265 ± 10  variable  Octanediol, citric acid  [21] 
PDC
c  −5–10 Up to 
3.14 ± 0.5 
322 ± 20  variable  1,10-decanediol 
Citric acid 
[22] 
Poly(diol 
citrates) 
−5–10 Up to 
11.2 
Up to 
502% 
variable  Citric acid; polyols  [22] 
PEG/PBT  –  8 to 23  500%  to 
1300% 
wide time 
range 
PEG and PBT segment  [23,24] 
PGCL
d  –  <1  Up to 250  >1.5  Short chain oligomers; 
glycolic acid; 
6-hydroxyhexanoic 
[24,25],  
TMC-DLLA
（dry）50:50 
e 
11  10  570%  <11  Short chain oligomers; 
D,L-lactic acid; TMC 
monomers 
[26–28] 
TMC-DLLA 
(dry) 20:80
f 
33  51  7  <11  Short chain oligomers; 
D,L-lactic acid; TMC 
monomers 
[26–28] 
TMC-CL 10:90
g > −17  23  –  >24  Short chain oligomers; 
Caproic acid 
[26–28] 
PEAs variable  variable  variable  wide  time 
range 
Short chain oligomers; 
diamines ,dicarboxylic 
acids 
[29] 
 
TS: tensile strength; Tg: Glass transition temperature; EB: Elongation at Break; DT: Degradation 
Time (months); 
aPGS: Poly(glycerol sebacate) 1:1 mole ratio polymerized for 77 h at 120 °C; 
bPOC: 
Poly(1,8-octanediol-co-citric acid) 1:1 mole ratio polymerized at temperatures ranging 80–120 °C 
for times ranging 1–4 days; 
cPDC: Poly(1,10-decanediol-co-D,L-lactic acid) Mole% shown in 
parenthesis with polymerizations at 130 °C for 3 days; 
e-f(TMC-DLLA): Poly(trimethylene 
carbonate-co-D,L-lactic acid) Mole% shown in parenthesis with polymerizations at 130 °C for  
3 days.; 
gPoly(trimethylene carbonate-co-caorolactone). Mole% shown in paraenthesis with 
polymerizations at 130 °C for 3 days. 
 
3.1. Biodegradable Polyurethanes 
 
The polyurethanes (PUs) have been the most popular group of biomaterials applied for biomedical 
devices for almost half a century, and this is because they provide great versatility in terms of tailoring 
their physical properties and biodegradation characteristics, as their properties can be tailored to range 
from biostable to rapidly degradable. Biostable PUs have been used commercially as biomedical 
implants since the 1960s, and improving the in vivo biostability of these materials has been 
investigated extensively [30]. In contrast to these biostable implants, biodegradable PUs are designed 
to undergo controlled biodegradation in vivo and promote new tissue ingrowths.   Int. J. Mol. Sci. 2009, 10                 
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The term “polyurethane” in this thesis refers to segmented polyurethanes, which are sometimes 
described as poly(ester-urethanes) or poly(ether-urethanes). Phase separation always occurs in 
segmented polyurethanes and the two phases are generally referred to as the ‘hard segment’ composed 
of diisocyanate and chain extender, and the ‘soft segment’ due to a more amorphous macrodiol. The 
structure of the segmented PUs can be described by the following general formula [30]: 
P— [D (CD)n— P] n 
where the P is the polyol, D is the diisocyanate and C is the chain extender. The soft segment is an 
oligomeric macromonomer comprising a chain having a low transition temperature (below the room 
temperature) and terminated by hydroxyl groups. The chain extender is usually a small molecule with 
either hydroxyl or amine end groups. The diisocyanate is a low molecular weight compound that can 
react with either the polyol or chain extender. The combination of the chain and the diisocyanate 
components is referred to as the hard segment of the polymer.   
 
3.1.1. Biodegradable Soft Segments 
 
Most biodegradable PU have soft segments composed of polyester or polyether macrodiols. The 
polyols used for biodegradable PUs synthesis are poly(ethylene oxide) (PEO), poly(propylene oxide) 
(PPO), poly(ε-caprolactone) (PCL), poly(D,L-lactide), poly(hydroxybutyrate) (P3HB and P4HB) and 
poly(glycolide). Woodhouse et al. synthesized a serious of PUs by using LDI and a novel amino acid 
ester chain extender in the hard segment, combined with PCL and/or PEO of different molecular 
weights as the soft segment [31–33].   
According to their research, the PEO-based PUs were weak, tacky, amorphous materials, while the 
PCL-based PUs were strong and elastomeric. PEO is used to enhance degradation, while PCL provides 
crystallinity. It was demonstrated that the scaffolds prepared from PCL-b-PEO-b-PCL soft segments 
block copolymers supported faster hydrolytic degradation than that from the PCL soft segments PUs 
[34]. Soft segments were also designed by combining the PCL-b-PEO-b-PCL segments with other soft 
segments, such as α,ω-dihydroxyoligo [((R)-3-hydroxybutyrate-co-(R)-3-hydrocyalerate)-ethylene- 
glycol] to produce a family of PUs called DegraPol
®, which was synthesized with either lysine methyl 
ester diisocyanate (LDI) or trimethylhexamethylene diisocyanate, along with the above soft segment 
[32,33,35]. Another example was the combination of the PCL-b-PEO-b-PCL segment with copolyester 
of adipic acid ethylene glycerol, diethylene glycol, and butanediol to produce another family called 
Diorez
® [36]. Other novel biodegradable soft segments were described in some references [37–45]. 
 
3.1.2. Diisocyanates   
 
A major limitation on the type of diisocyanate that can be used in biodegradable polymers for tissue 
engineering applications is the toxicity of the degradation products. As alternatives to 
4,4’-methylenebis (phenylisocyanate) (MDI), lysine methyl ester diisocyanate (LDI) and 
1,4-diisocyanatobutane (BDI) have been used to synthesize biomedical polyurethanes. Potential 
degradation products from these aliphatic diisocyanates are the amino acid lysine and the biological 
diamine putrescine. A lot of studies have reported that PUs biomaterials prepared from lysine-derived Int. J. Mol. Sci. 2009, 10                 
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polyisocyanates biodegrade in vitro and in vivo to noncytotoxic decomposition products [46–48]. 
Some of the diisocyanate that have been applied in the synthesis of biodegradable polyurethanes are 
shown in Table 2. 
Table 2. Diisocyanates in biodegradable PUs [49]. 
Diisocyanates  Name and Abbreviation 
CH2 OCN NCO ( )
4  
Butane diisocyanate ( BDI) 
CH2 OCN NCO ( )
6  
Hexamethylene diisocyanate (HDI) 
OCN C H3
C H3
C H3 CH2 OCN 
Isophorone diisocyanate (IPD) 
CH2 NCO CH
NCO
C
O
OC H 3 ( )
4  
Lysine diisocyanate (LDI) 
CH2 NCO C CH2
CH3
CH3
CH
CH3
CH2 CH2 OCN
 
Trimethylhexamethylene diisocyanate (TMDI) 
 
3.1.3. Biodegradable Chain Extenders   
 
Some degradable chain extenders which incorporate amino acids have been previously developed. 
These degradable chain extenders are always diamines [50] (see Figure 1, for example).   
 
Figure 1. Structure of degradable chain extender used by Skarja and Woodhouse [16,51]. 
CH2 CH2 OC
O
CH O C
O
CH N H2
CH2
CH2
NH2
 
The chain extenders with phosphate ester linkages were degradable [52]. The phosphoester linkages 
in the backbone of the PU confer biodegradability on the polymer. However, no data related to the 
degradability of the PU was reported. A chain extender based on DL-lactic acid and ethylene glycol 
was reported [16]. These kinds of chain extenders were degradable and could accelerate hard segment 
degradation. The structure of the degradable chain extender is shown in Figure 2.   
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Figure 2. Structure of degradable chain extender based on lactic acid and ethylene glycol [16]. 
O HC H
CH3
C
O
OC H 2 CH2 OH
 
 
3.1.4. Biodegradation Mechanism and Degradation Rate  
 
Biodegradable PUs are designed to undergo enzymolysis or hydrolysis. The degradation 
mechanisms of hydrolysis were summarized by Guelcher [50,51]. The hydrolysis of ester linkages 
produces α-hydroxy acids, urethane and urea fragments with terminal acid groups. For lysine-derived 
polyisocyanates, hydrolysis of urethane linkages to lysine has been reported [37,44,45]. 
The degradation rate for biodegradable PUs is governed by many factors [52]. Most studies have 
suggested that the degradation rate was mainly controlled by polyester polyol composition [53,54]. 
PUs with amorphous soft segments have been observed to degrade more rapidly than those with 
semicrystalline soft segments, and those with hydrophilic soft segments have been reported to degrade 
more quickly than those with hydrophobic soft segments [55]. Most studies concluded that hydrolysis 
is the prevalent degradation pathway for in vivo degradation of poly(ester urethanes) [56–59]. Of all 
kinds of bonds present in poly(ester urethanes), the ester ones are the most susceptible to hydrolysis, 
while urethane and urea linkages are resistant to hydrolysis, and it has been reported that the latter are 
only enzymatically degraded [54,55,59,60]. All of these results suggest that the soft segment bonds 
will hydrolyse quicker than hard segment bonds, so the degradation rate of the biodegradable PUs is 
mainly controlled by their soft segments. The degradation of some polyester urethanes can also be 
controlled by the degree of crosslinking [61].   
 
3.2. Biodegradable Polyphosphazenes   
 
Polyphosphazenes (PNs) are a class of polymers of great potential for biomedical applications. 
These polymers consist of an inorganic backbone of alternating phosphorus and nitrogen atoms 
bearing side group substituents at the phosphorus atoms. Interest in these polymers is due to the fact 
that their properties are mainly dictated by the nature of the phosphorus substituents so that PNs for a 
wide range of applications can be obtained by the appropriate choice of the backbone derivatives. The 
degradation products of these degradable PNs are usually nontoxic, such as phosphates, ammonia and 
the corresponding side groups. The structure of the PNs is shown in Figure 3. The R and R’ in Figure 3 
stand for organic groups or organometallic groups.   
 Int. J. Mol. Sci. 2009, 10                 
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Figure 3. Structure of polyphosphazenes [62]. 
NP
n
R'
R  
The physical properties of polyphosphazenes depend on the nature and the number of substituents. 
Because of the low rotational energy around the N-P bond (3.38 and 21.8 kJ/mol, respectively, for 
polyditrifluoroethoxy and polydiphenoxyphosphazene [63]) the structure of polyphosphazene has a 
high degree of freedom and a low glass transition temperature, so most PNs exhibit elastomeric 
properties. Small and unhindered substituents such as alkoxy groups give very low Tg, below −60 °C 
(−105 °C for n-butyl). Aromatic rings give more stiffness, leading to a transition temperature of 
−34–0 °C with one ring, and 0–100 °C with two rings [64]. The freedom of movement of the chains 
can also be restricted by interatomic interactions. This is particularly true of primary amine substituted 
polymers which exhibit a Tg about 100 °C higher than polymers substituted with the corresponding 
alcohols. The P-N backbone flexibility can also make these polymers undergo structure changes in 
solid state [65]. The structure-properties relationship of some PNs are listed in Table 1 in Honarkar’s 
review [18].   
The phosphorus-nitrogen backbone can be rendered hydrolytically unstable by substituting with 
appropriate side groups. Allcock and co-workers, who have explored extensively the field of 
polyphosphazenes [66–69], suggested that the biodegradable PNs generally comprise a hydrophilic 
substituent in a ratio corresponding to the required hydrophilicity, and an active principle either grafted 
or merely trapped in the polymeric network. Optionally a substituent capable of accelerating the 
hydrolysis of the chain by an assistance mechanism can also be added. The most frequently mentioned 
hydrophilic substituent is monomethylamine. polyethers [70], glucoses [71], and imidazole [72]. The 
presence of amino-acid esters among the substituents, in particular ethyl glycinate, helps the hydrolysis 
of the polyphosphazene backbone. 
PNs can degrade by both surface and bulk erosion. As in the case of other hydrolytically sensitive 
polymers, the rate of degradation of PNs depends on several factors such as the lability of the bond, 
ease of water permeability, which in turn depends on the hydrophilicity or hydrophobicity of the 
matrix. Generally speaking, biodegradable PNs can be classified into two groups depending on the 
type of side group substituents: those substituted with amines and those substituted with activated 
alcohols [73,74]. The degradation models of these two kinds of biodegradable PNs were reviewed by 
Lakshmi [74]. 
 
3.2.1. Aminated PNs 
 
Aminated PNs comprise the largest and most extensively studied class of biodegradable PNs. 
Allcock and co-workers have synthesized a series of aminated PNs since 1966 [75–79]. The structures 
of these biodegradable aminated PNs are shown in Figure 4. Int. J. Mol. Sci. 2009, 10                 
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Among these PNs, the amino acid ester ones are perhaps the most extensively studied ones for 
biomedical applications. Figure 4(a) presents the imidazole-substituted PNs. The structure of  
Figure 4(b) was found to be the least stable among the aminated PNs synthesized. Figure 4(c) shows 
the structure incorporated side groups with hydrolytically sensitive ester functions [78]. Figure 4(d) 
gives an example of a highly pH-sensitive PN
 [79].  
 
Figure 4. Structures of biodegradable aminated polyphosphazenes [74]. 
NP
N H
N H
CHR
CHR
C
C
O
O
OR'
OR'
n  
NP
N
N
N
N
n
 
(a)                            ( b )  
P
N H
HN
N
CHR
CH2 CO
O
CH2 CH3
C
O
OC H C
O
OC H 2 CH3
n
 
(c) 
NP
N HC H 2 C
O
NH2 CO
O
N H2 CH2 CN H 2
O O
CO
n
 
(d) 
 
Two mechanistic pathways have been proposed for the hydrolytic instability of aminated PNs
 
[74,80]. The degradation of these compounds can be triggered by the protonation of atoms in the 
skeleton or in the side groups. Protonation of skeletal nitrogen would lead directly to ring cleavage. 
This could ultimately lead to the conversion of the compound to ammonium ion, phosphoric acid and 
the free amine salt. protonation of side group nitrogen could take place, followed by nucleophilic 
attack by water at phosphorus, yielding a monohydroxycyclophosphazene, which, on further 
hydrolysis, would undergo ring cleavage and eventual degradation.   
The ester functionality may be involved in the breakdown of the polyphosphazene skeleton via 
three different mechanisms. In the first, water would hydrolyze the ester unit to form the 
corresponding polymer-bound amino acid. The carboxylic acid unit could then attack a nearby Int. J. Mol. Sci. 2009, 10                 
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phosphorus atom in the polymer chain. This species would then react further with water to release the 
amino acid and to form a hydrolytically unstable phosphazane, which would ultimately break down to 
phosphates and ammonia. In a second mechanism, the presence of water could facilitate an attack on 
the polymer backbone by the ester functionality itself. Water molecules could then react with the 
unstable phosphorus–ester bond. In a third mechanism, water would displace the amino acid esters 
from the phosphorus atoms to form a hydroxyphosphazene. This species could rearrange in the 
presence of water to a phosphazane. The phosphazane would then react with water to yield phosphates 
and ammonia. It was suggested that all three could occur simultaneously, although evidence for all 
three mechanisms was found [74,77,80]. 
The degradation rate can be modulated by some methods. It was shown by Allcock et al. [77] that 
the hydrolytic sensitivity of the polymers was found to decrease as the size of the ester groups 
increased. Similarly, the larger the group linked to the α-carbon atom of the amino acid residue, the 
more stable was the polymer to hydrolysis, so the degradation rate can also be modulated by 
incorporating suitable co-substituents along with the appropriate amino acid ester groups. The 
degradation rate was also affected by the pH. Ibim et al. [81]. found that the degradation rate was 
relatively much slower in neutral and basic solution (pH 7.4 and 10.0) than that in acidic solution. 
Results showed that more than 80% of the polymer depredated in 35 days at pH 2.0.   
 
3.2.2. Alkoxy-Substituted PNs 
 
The glyceryl-substituted polyphosphazene [Figure 5(a)] was first synthesized by Allcock and Kwon 
[82]. Structures of PNs substituted with glucosyl and methyl amino groups are shown in Figure 5(b) 
and esters of glycolic or lactic are also shown in Figure 5(c). They were reported to be hydrolytically 
labile [83,84]. The degradation products of the glucosyl and methyl amino substituents are presumed 
to be phosphate, glucose, ammonia and methylamine. The degradation process of glycolic or lactic 
PNs was described as: Water molecules could displace ethyl glycolato side units or hydrolyze the 
pre-ester function to the acid, and the pendent carboxylic acid could then induce skeletal degradation. 
The in vitro and in vivo biocompatibility of biodegradable polyphosphazenes has been extensively 
investigated by Laurencin et al. [85–90]. Most of the amino acid ester polyphosphazenes elicited 
minimal to mild tissue responses when implanted subcutaniously in a rat model. Many of the amino 
acid ester polyphosphazenes have shown excellent osteocompatibility and have been investigated as 
matrices for bone tissue engineering [91]. Recently a polyphosphazene-self setting calcium phosphate 
composite cement system has been developed by taking advantage of the favorable interactions 
between polyphosphazenes side groups and calcium phosphate ceramics [92–95]. 
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Figure 5. Structures of biodegradable Alkoxy-substituted polyphosphazenes [74]. 
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3.3. Network Polyesters Synthesized with Polyatomic Acids and Polyatomic Alcohols 
 
3.3.1. Poly(polyol sebacate) 
 
Wang and coworkers [19] first reported the use of glycerol and sebacic monomers to produce a 
novel elastomeric material poly(glycerol sebacate) (PGS) for potential application in soft tissue 
engineering in 2002. Since glycerol is the basic building block of lipids, and sebacic acid is the natural 
metabolic intermediate in fatty acid oxidation [96,97], the degradation products of PGS are nontoxic. 
In addition, glycerol and copolymers containing sebacic acid have been approved for their application 
in medical applications by the U.S. FDA [98]. PGS demonstrated a favorable tissue response profile 
compared with PLGA, with significantly less inflammation and fibrosis and without detectable 
swelling during degradation. 
Their simple synthesis process, adjustable mechanical and biodegradation properties, and good 
biocompatibility made the PGS elastomers excellent candidates for soft tissue engineering. They have 
already been investigated in tissue engineering applications [99–102].   
PGS was synthesized by condensation polymerization. The structure of PGS is shown in Figure 6. 
To obtain the elastomers, they first synthesized a prepolymer and then poured an anhydrous 
1,3-dioxolane solution of the prepolymer into a mold for curing and shaping under a high vacuum. The 
PGS obtained by Wang and coworkers was a kind of thermoset elastomer with a Young’s modulus of 
0.282 ± 0.025 MPa, a tensile strain of at least 267 ± 59.4% and a tensile strength was at least 0.5 MPa. 
The mechanical properties of PGS were consistent with that of some common soft tissues. Liu and his 
coworkers [103–105], also investigated the effects of the molar ratio and the reaction conditions on the 
elasticity, strength, biodegradation and thermal processing abilities. The different molar ratios 
(glycerol/ sebacic acid) used in their work were 2/2, 2/2.5, 2/3, 2/3.5 and 2/4. They also prepared the Int. J. Mol. Sci. 2009, 10                 
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thermoplastic PGS elastomer by a two-step method. Results demonstrated that the mechanical 
properties and degradation rates of products could be flexibly adjusted by the alteration of the  
molar ratio. 
Figure 6. Structure of PGS [19]. 
H2CC H
OR
CH2 OC
O
CH2 C
O
O
n
()
8
 
 
The degradation rate can be easily controlled by molar ratios and crosslinking density, which is 
related with the reaction temperature and time. The in vitro degradation was carried out in PBS at 
37 °C under agitation. PGS lost 17 ± 6% of its mass, but during the same time in vivo, the copolymer 
was completely absorbed. The degradation rate in vivo is always quicker than that in vitro because of 
the enzymes originating from inflammatory cells or macrophages may attack the polymer bonds and 
catalyze the degradation process. The in vivo experiments showed that the mechanical properties 
(measured as compression modulus) decreased linearly and in parallel with the degradation of PGS, 
suggesting surface erosion as the mechanism of degradation [20]. Another important finding was that 
the shape of PGS was maintained during the degradation unlike that of PLGA. It was also proposed 
that PGS may perform well as a conduit material in peripheral nerve regeneration applications [99]. 
Beside the PGS, Bruggeman and his coworkers [106] have developed a family of thermoset 
poly-(polyol sebacate) (PPS) polymers. The material properties of PPS polymers can be tuned by 
altering the polyol monomer and the reacting stiochiometric ratio of sebacic acid. These thermoset 
networks exhibited tensile Young’s moduli ranging from 0.37 to 378 MPa, with maximum elongations 
at break from 10.90% to 205.16%, and Tg ranging from −7–46 °C. 
Three general criteria led to the selection of polyols as monomers [106]: 1) non-toxic, 2) 
multi-functional to allow the formation of randomly crosslinked networks, as well as a wide range of 
crosslink densities, and 3) allow formation of hydrolysable esters in polycondensation polymerizations. 
xylitol, mannito and maltitol has been chosen as the monomers, corresponding to poly(xylitol sebacate) 
(PXS) 1:1 and PXS 1:2, poly(sorbitol sebacate) (PSS) 1:1 and PSS 1:2, poly(mannitol sebacate) (PMS) 
1:1 and PMS 1:2, and poly(maltitol sebacate) (PMtS). 
The  in vitro degradation under physiological conditions was investigated. After 105 days of 
degradation, PXS 1:1 and 1:2 revealed a mass loss of 1.78% and 1.88%, respectively. PXS 1:1 did not 
reveal a similar mass loss profile as PSS 1:1 (15.66%) and PMS 1:1 (21.90%). PSS 1:1 and PMS 1:1 
had degraded more than their corresponding 1:2 stiochiometries: PSS 1:2 had degraded 5.57 ± 1.00% 
of their original mass, and PMS 1:2 degraded 9.00% at this time. PMS 1:4 showed the least mass loss 
of 0.76%. In the in vivo degradation study, The PSS 1:1 elastomer appeared to have fully degraded 
after 12 weeks, without detectable trace despite repetitive sectioning of the implantation area. The  
in vivo degradation mechanism of PXS elastomers is dominated by surface erosion. The degradation 
rates in vitro, however, did not correspond to that in vivo. 
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3.3.2. Poly(diol-citrates) 
 
Citric acid was chosen as a multifunctional monomer to enable network formation. It is a nontoxic 
metabolic product of the body (Krebs or citric acid cycle), and has been approved by the FDA for its 
use in humans. It was found that the citric acid can be reacted with a variety of hydroxyl containing 
monomers at relatively mild conditions [21], meanwhile, it can also participate in hydrogen bonding 
interactions within a polyester network.   
Yang and coworkers did the most efforts on the development of network polyester based on citric 
acid [21]. They investigated the reaction of citric acid with a series of aliphatic diols (from  
3–16 carbon chains) and polyether diols such as polyethylene oxide, in which 1,8-octanediol (POC) 
and 1,10-decanediol (PDC) have been studied detailedly. The rationale behind these poly(diol-citrates) 
elastomers is [22]: 1) the use of non-toxic, readily available and inexpensive monomers. For example, 
citric acid is chosen as a multifunctional monomer that will be reacted via polycondensation with a 
difunctional monomers (diol) to form a cross-linked co-polymer; 2) incorporation of homogeneous 
biodegradable crosslinks to confer elasticity to the resulting material and leave behind some unreacted 
functional groups, which can be used for surface modifications; 3) the availability of various diols 
which provide flexibility to tune the mechanical and degradation characteristics of the resulting 
copolymer, and 4) the establishment of intermolecular hydrogen bonding interactions, which should 
contribute to the mechanical properties of elastomers. 
The significant advantage of poly(diol citrates) when compared to existing biodegradable 
elastomers is that synthesis methods can be conducted under very mild conditions. Poly(diol citrates) 
were synthesized by reacting citric acid with various diols to form a covalent cross-linked network via 
a polycondensation reaction without using exogenous catalysts. The reaction scheme is shown in 
Scheme 1.   
 
Scheme 1. Synthesis of poly(diol citrates) [21]. 
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The mechanical properties, degradation and surface characteristics of poly(diol citrates) could be 
controlled by choosing different diols as well as by controlling synthesis conditions such as 
crosslinking temperature and time, vacuum and initial monomer molar ratio.   
The tensile strength of poly(diol citrates) was as high as 11.15 MPa and Young’s modulus ranged 
from 1.60 to 13.98 MPa. Elongation was up to 502%. the tensile strength and Young’s modulus 
increased and the elongation at break  decreased as the post-polymerization temperature and time 
increased [22], It was reported that POC is a strong elastomeric, biodegradable, and hydrophilic 
“cell-friendly” material [21]. The tensile strength was as high as 6.1 MPa and the Young’s moduli 
ranged from 0.92 to 16.4 MPa. The maximum elongation at break was 265% of initial length. Int. J. Mol. Sci. 2009, 10                 
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The degradation rate of POC is modulated by changing the post-polymerization temperature, 
reaction time, and the molar ratio of monomers. POC post-polymerized under mild conditions (low 
temperature, no vacuum) has a faster degradation rate than that post-polymerized under relatively 
tough conditions (high temperature, with vacuum). The totally degradation time of POC in PBS at 
37 °C is about 6 months. Depending on implant location, the degradation rate may be faster in vivo due 
to enzymatic or cellular effects. Diols with decreasing number of methylene units result in increasing 
degradation rates. 
Since the crosslink density is directly proportional to the strength but inversely proportional to the 
degradation rate, tailoring the properties of POC would be difficult if only the crosslink density can be 
varied. Increasing the molar ratio of citric acid increases the degradation rate of the copolymer without 
sacrificing its tensile strength. The introduction of N-methyldiethanolamine (MDEA) into the 
cross-linking net work significantly increased the degradation rate, while allowing the achievement of 
relative high tensile strength and Young’s modulus [107].   
Composite materials of poly(diol citrates) were further investigated by Yang and his coworkers. 
They have prepared poly(diol citrates)/HA (hydroxyapatite) [107], poly(diol citrates)/chitosan [108], 
and poly(diol citrates)/PLA [108] composites with properties that are relevant to orthopedic and 
vascular tissue engineering applications.   
In order to improve the mechanical properties of poly(diol citrates) and poly(glycerol sebacate), 
such as tensile strength and load bearing abilities, Dey and Yang et al. [61] developed a new class of 
biodegradable crosslinked urethane-dropd polyester elastomer. This class of polymers termed 
crosslinked urethane-doped polyesters (CUPEs) combines the advantages of fully elastic and 
biocompatible/hemocompatible crosslinked polyester networks with mechanically strong 
polyurethanes. Degradation studies were conducted in both phosphate buffered saline (PBS; pH 7.4) 
and NaOH solutions (0.01 M and 0.05 M). In vitro degradation studies showed that degradation rate 
was observed to be a function of the choice of diol, the isocyanate content, and the post-polymerization 
conditions. The polymers with higher isocyanate content exhibited faster degradation rates in both PBS 
and NaOH. Increasing the polymerization time made the CUPE polymers more resistant to degradation. 
Increasing the hydrophilicity of the diol used in the synthesis resulted in faster degradation rates as 
evidenced by the faster rate of degradation of the CUPE polymers containing poly(ethylene glycol) 
(PEG) in different ratios.   
Besides the poly(polyol sebacate) and poly(diol-citrates), other multicomponent network polyester 
bioelastomers were also investigated. A series of network polyester bioelastomers– 
poly((1,2-propanediol-sebacate)-citrate)s (PPSCs), were synthesized by melt polycondensation of the 
polyfunctional monomer citric acid and oligomeric diol of 1,2-propanediolsebacate which was 
synthesized by controlled condensation reaction of difunctional monomers 1,2-propanediol and 
sebacic acid [109]. The mechanical properties, degradation and hydrophilicity of PPSC elastomers 
could be controlled by initial CA monomer molar ratio as well as by controlling the synthetic 
conditions such as cross-linking time. It was suggested that the synthesis of PPSC can also be carried 
out under mild conditions without addition of toxic catalysts, and they possess controllable mechanical 
and degradation properties which make them a good candidate for drug delivery and ther biomaterials. Int. J. Mol. Sci. 2009, 10                 
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The poly(diol citrates) have been designed into small-diameter blood vessel tissue engineering 
scaffold [110], nanoporous structure for drug-delivery reservoirs [111] and cartilage tissue engineering 
scaffold [112].  
 
3.4. Biodegradable Poly(ether ester)   
 
PEE copolymers were consisted of soft segments of polyethers and hard crystalline segments of 
polyesters. Depending on the polyether-polyester ratio, poly(ether ester) (PEE) copolymers exhibit a 
wide range of mechanical and biodegradation behaviors. 
In all kinds of PEEs, poly(ethylene glycol)/poly(butylene terephthalate) (PEG/PBT) have been 
widely researched in the biomedical field. Segmented PEG/PBT multi-block copolymers are 
thermoplastic elastomers, which were both abbreviated as ‘PEG/PBT’ or ‘PEO/PBT’ in references. The 
‘PEG/PBT’ form is adopted in this review. The composition of the block copolymers is abbreviated as 
a PEG b PBT c, in which a is the molecular weight of the PEG used, b is the weight percentage of PEG 
soft segments and c is the weight percentage of PBT hard segments. 
In 1972, the potential medical application of PEG/PBT was accidentally discovered by Annis et al. 
[113]. When the PEG/PBT was implanted in animal body, they found that collagenic encystations was 
connected more closely with the tissue as increased of the PEG content. After the concept of tissue 
engineering formally proposed in 1988, the degradable PEEs elastomers attracted many researchers’ 
eyes. In the early 1990’s, Fakirov and and coworkers [114–124] prepared a series of PEG/PBT 
copolymers with different soft and hard segments content by using ester exchange method. 
Poly(ethylene glycol) (PEG 1000), 1,4-(butanediol) and dimethyl terephthalate were chosen as the raw 
materials, and titanate as the catalyst in their research. The effects of the initial ratio of the raw 
material on the physical and chemical properties were studied. At the same time, scholars in Holland 
such as Blitterswijk, Feijen , Bezemer, et al. widely studied the application of PEG/PBT copolymers in 
bone, cartilage and skin tissue engineering as well as in drug delivery system. Few years latter, the 
commercial product of PEG/PBT copolymers named PolyActive
® was firstly developed by the HC 
corporation in Holland. The structure of PolyActive
® was shown in Figure 7. After that the Isotis 
Biotechnology Corporation and some research organization (like Leiden University) worked together 
to develop tissue engineering scaffold by use of PolyActive
®. The first study of them showed that the 
PolyActive
® could be used in bone replacement, artificial periosteum, wound dressing, artificial skin 
and drug control release carrier. Other clinical studies have been focused on the artificial tympanic 
membrane application [125,126] ventilation tubes, adhesion barrier [127], elastic bioactive coatings on 
load-bearing dental and hip implants [128] and also for wound healing purposes [129]. 
 
Figure 7. Structure of PolyActive
® [23]. 
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Another kind of commercial biomedical material named Politerefate
TM (Figure 8) has also been 
developed by inducing the phosphate groups into the PBT segments. Politerefate
TM has been widely 
investigated in nerve tissue engineering and control releasing drug delivery carrier [130,131].   
 
Figure 8. Structure of Politerefate
TM [23].   
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A diverse family of customized polymers can be created by varying the amount and length of each 
of the two building blocks. The polymer matrix characteristics such as rate of controlled release, 
degradation, swelling and strength can be precisely controlled by the appropriate combination of the 
two copolymer segments. The segmented copolymers are phase separated, which is more obvious for 
polymers with high hard segment contents and polymers containing high molecular weight PEG. 
Tensile strengths were reported varies from 8 to 23 MPa and elongation at break changes from 500% 
to 1300%. Water-uptake ranged from 4% to as high as 210% [23]. Various in vivo studies have been 
performed to assess the biocompatibility of PEG/PBT copolymers upon implantation in soft and hard 
tissue [132–136]. Results can be concluded as that PEG/PBT copolymers did not induce any adverse 
affect on the surrounding tissue and thus showed a satisfactory biocompatibility. 
The  in vitro degradation of PEG/PBT copolymers occurs both by hydrolysis and oxidation, in 
which hydrolysis is the main degradation mechanism. In both cases, degradation is more rapid for 
copolymers with high PEG content [137]. Reed et al. investigated the degradation mechanics of 
PEG/PET copolymers whose structure is similar to that of the PEG/PBT. Although there are ether 
bonds, ester bonds among PET and ester bonds among the PEG/PET segments, only the last one was 
easy to hydrolyze [138]. Van Blitterswijk et al. [133] deduced that the degradation mechanics of 
PEG/PBT was similar to those of the PEG/PET. They pointed out that the ester bonds between the 
PEG and PBT segments hydrolyzed at first. The degradation products were PEG segments and low 
molecular PBT segments. The degradation rates were influenced by the composition, temperature, pH, 
enzyme content et al. The degradation rates increased as the PEG content, temperature, pH value 
increased, in which the component’ s content is the most impact factor on the degradation rates. 
Copolymers with high PEG contents degraded more rapidly than those with lower PEG contents. The 
initial degradation is restricted to the amorphous soft PEG segment. The fact that PEG was detected 
alone as major degradation product proved this assumption [139]. 
In vivo there are also two degradation pathways that are expected to take place. The first route 
involves hydrolysis of ester bonds in the PBT part or of ester bonds connecting PEG segments and 
terephthalate units. Besides of the hydrolysis, it has been suggested that in vivo degradation of the 
polymers with aliphatic ether groups involves phagocyte-derived oxidative degradation of PEG by a 
radical mechanism initiated at random along the chain [140]. Implantation of the copolymer devices 
provokes a foreign body response. During the implantation, specific activated cells such as 
macrophages release enzymes and superoxide anion radicals, which can combine with protons to form 
hydroperoxide radicals. So the oxidation degradation happened.   Int. J. Mol. Sci. 2009, 10                 
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From the results of the accelerated hydrolysis experiments of 1000 PEG71PBT29 in PBS at 100 °C, 
the degradation products consisted of a fraction with high contents of PEG that was soluble in PBS and 
a PEG/PBT fraction that was insoluble at room temperature. Results from different in vitro and in vivo 
degradation experiments indicated that PEG/PBT degradation is a slow process and generates 
insoluble polymeric residues with high PBT contents. A part of the PBT fraction might remain in the 
body at late stages of degradation leading to incomplete degradation of PEG/PBT copolymers in vivo 
on the long term. However, the crystalline PBT fragments seem well tolerated by the surrounding 
tissues [141]. 
Except the lineal thermoplastic PEG/PBT elastomer composed with hard soft segments, the 
crosslinking network PEE was synthesized by PEG and polyprotic acid, such as citric acid to produce 
the poly(PEG-co-CA) (PEC) [142]. The pre-polymer synthesized by carrying out a condensation 
reaction between poly(ethylene glycol) and citric acid under atmospheric pressure, and then 
post-polymerized and cross-linked the pre-polymer in a mould at 120 °C. A relatively simple synthesis 
of PEC that can be carried out under mild conditions, especially without adding toxic catalysts or 
cross-linking reagents makes it a good candidate for biomaterials. The condensation reaction between 
PEG and citric acid is shown in Scheme 2. The degradation rate of the elastomer can be varied over a 
comparatively wide time range by controlling the cross-linked time and the initial monomer  
molar ratio. 
 
Scheme 2. Reaction formula of condensing PEG and citric acid [142]. 
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3.5. Poly(ε-caprolactone) Copolymers with Glycolide or Lactide 
 
Poly(α-hydroxy acids), mainly polylactide (PLA) and polyglycolide (PGA) homo- and copolymer 
are the first choice compared with other biodegradable polymers in preparation of biomaterials for 
tissue repair [143]. However, the stiffness and plastic deformation characteristics have limited their 
applications. Compared to the poly(α-hydroxy acids), PCL is a relatively flexible and biodegradable 
biomaterial. The safety of the PCL as several medical and drug delivery devices has been approved by 
FDA [144]. However, it seems the degradation rate of PCL is too slow for most tissue engineering 
applications. The total degradation of PCL may take two to three years. The copolymerizations of PCL 
with PLA or PGL can produce a novel material which will overcome the drawbacks of every single 
constituent, such as to provide better control over the degradation and mechanical properties without 
sacrificing biocompatibility. Specially, the copolymers are elastomeric which made themselves good 
candidate for soft tissue engineering [25], such as articular cartilage [145] and mechano-active 
vascular [146,147]. 
The poly(glycolide-co-caprolactone) (PGCL) and poly(lactide-co-caprolactone) (PCLA) 
copolymers were mainly synthesized by ring-opening polymerization. The reaction diagrams are 
shown in Scheme 3 and Scheme 4, respectively.   Int. J. Mol. Sci. 2009, 10                 
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Scheme 3. Synthesis of (PGCL) [24]. 
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Scheme 4. Synthesis of (PCLA) [24]. 
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The degradation rate of PGCL or PCLA can be varied over a wide time range by tightly controlling 
the ratio between each kind of the monomers. Although the degradation products were not 
characterized, as degradation occurs through the hydrolysis of the ester bonds, the degradation 
products should contain short chain oligomers and the corresponding monomer hydroxyl acids 
(glycolic acid and 6-hydroxyhexanoic acid). All the copolymers degraded faster than each of the 
homopolymers. In Lee’s work, PGCL scaffolds (1:1 mole ratio) lost 3% of their initial mass after 
being incubated in PBS for two weeks and lost 50% after six weeks [25]. The result of Cohn’s work 
showed that the tensile strength of PCLA copolymers gradually dropped from their high initial levels 
(around 30–34 MPa) to 2–3 MPa after incubation in PBS for three months. Most of these copolymers 
remained flexible elastomers for a significant period of time in PBS [148]. In the in vivo degradation 
study, the implanted PCLA scaffolds displayed a slow degradation on time, whereas caprolactone units 
were degraded faster than lactide. This could be explained by the fact that amorphous regions 
composed of mainly CL moieties degraded earlier than hard domains where most of the LA units were 
located [149]. Based on the poly(α-hydroxy acids) and PLA, some other multiblock copolymers were 
synthesized, in which polylactide-co-poly(glycolide-co-caprolactone) was reported to be a 
biodegradable shape-memory polymer [150].   
 
3.6. Poly(1,3-trimethylene carbonate) and Copolymers   
 
Poly(1,3-trimethylene carbonate) (PTMC) is a rubbery and amorphous polymer [151]. It has 
already been investigated for the preparation of biodegradable elastomeric porous structures for soft 
tissue engineering scaffolds, specifically nerve and heart tissues [26,152]. Although PTMC is rubbery 
by itself, it is not an ideal candidate for implanted biomedical applications, because its degradation 
rates are difficult to predict. For example, although high molecular weight PTMC   
(Mw: 500,000-600,000 g/mol) degrades very slowly (more than two years) when tested in vitro [153], 
it degrades within 3-4 weeks when implanted in vivo, the faster degradation most likely being due to 
enzymatic activity [27]. In order to obtain materials with suitable mechanical properties and Int. J. Mol. Sci. 2009, 10                 
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degradation rates, TMC was copolymerized with either D,L-lactide (DLLA) or ε-caprolactone  
(CL) [26,152].   
The properties of TMC–DLLA copolymers range from hard and brittle to rubbery and soft as the 
percentage of DLLA decreases. The copolymers with 20 to 50 mol% TMC are of most interesting in 
soft tissue engineering. The TMC-DLLA copolymers with 50 mol% TMC are highly flexible and 
strong with an elongation at break of 570% and an ultimate tensile strength of 10 MPa. The reaction of 
TMC with DLLA is shown in Scheme 5.   
 
Scheme 5. Synthesis of statistical poly(trimethylene carbonate-co-D,L-Lactide). 
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TCM-CL based materials are all flexible. The strength increased as the CL content increased [26]. 
The reaction of TMC with CL is shown in Scheme 6. 
 
Scheme 6. Synthesis of statistical poly(trimethylene carbonate-co-caprolactone). 
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In vitro degradation of TMC-DLLA was examined by incubating samples in PBS for up to two 
years [154]. The copolymers degraded much faster than the parent homopolymers, which is because 
the ester bonds are more labile to hydrolysis than the carbonate bonds. For P(D,L-LA), a continuously 
decrease of the mechanical properties was observed during the period of study, which could be related 
to the decrease in molecular weight (8% of its initial value after 60 weeks). In the case of PTMC, it did 
not show any significant decrease in molecular weight, and only a relatively small deterioration of the 
tensile strength (53%) was observed during this 60-week study. 
It was observed that the degradation speed of poly(TMC-DLLA) (50:50) was the fastest of all 
samples. It degraded into the small pieces only after three months. Poly(TMC-DLLA) (20:80) became 
brittle, but still held its integrity after four months, while poly(TMC-DLLA) (79:21) lost its tensile 
strength after five months of degradation. Although the degradation products were not examined, one 
would expect that hydrolysis of the ester bonds will yield short chain oligomers and the  
original monomers.   
The in vitro degradation rate of the TMC-CL based copolymers was much slower than that of the 
TMC-DLLA based copolymers. In accordance with the small decrease in molecular weight during the 
time of the study, no significant changes of water uptake, molecular weight distribution or mass loss 
were observed for the TMC-CL copolymers. The mechanical properties of TMC-CL copolymers as a Int. J. Mol. Sci. 2009, 10                 
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function of degradation time decreased as the molecular weight decreased. All polymers maintained 
good mechanical performance, even after one year of degradation [154]. 
The degradation and the tissue response evoked by PTMC and copolymers of TMC with either  
52 mol% DLLA or 89 mol% CL were evaluated in vivo by subcutaneous implantation of polymer 
films in rats for periods up to one year. PTMC specimens were extensively degraded after three weeks 
and, as confirmed by histology, totally resorbed in less than a year [27]. A fast linear decrease in 
thickness and mass without a change in molecular weight was observed. It is concluded that in vivo, 
PTMC is degraded via surface erosion involving cellular-mediated processes. The degradation of the 
copolymers was slower than that of PTMC, taking place via autocatalyzed bulk hydrolysis, 
preferentially of ester bonds. The TMC-DLLA copolymer degraded 20 times faster than the TMC-CL 
one. As the degradation of the TMC-CL copolymers was so slow, a mature fibrous capsule remained 
throughout the year. The TMC-DLLA copolymer became smaller and lost 96% of its total mass over 
the time course of this study. Histological results showed a normal inflammatory response and foreign 
body reaction. However, in the later stages of the study, the TMC-DLLA copolymers showed a second 
inflammatory reaction triggered by the cellular removal of residual polymer. 
 
3.7. Poly(ester amide)s 
 
Poly(ester amide)s (PEAs) are an interesting group of potentially biodegradable materials since due 
to the hydrogen bonding ability of the amide bonds and biodegradability imparted by the ester bonds, 
these co-polymers have good mechanical and thermal properties. Polyamides generally display better 
mechanical and thermal endurance than the corresponding polyesters, thanks to the formation of strong 
hydrogen bonding between the amide linkages of individual chains. Polyesters, on the other hand, are 
generally superior in flexibility, solubility, and hydrolytic susceptibility, and can thus be designed to 
degrade within a reasonable time-scale. The combination of polyester and polyamide moieties leaves 
us with tremendous opportunities of tuning the resulting properties to fit a desired profile.   
PEAs can be generally classified into two major categories, depending on the sources that provide 
amide blocks: those synthesized from amino acids and those from non-amino acids source like 
aliphatic diamines. The non-amino acid based PEAs were initially reported by Barrows and others 
[155–157] and were synthesized from polyesterification of two types of amide diols, A radiolabel 
study of the degradation products in rats suggested that those non-amino acids based PEAs would 
degrade via the hydrolysis of their ester linkages, while their amide blocks remained stable. 
To overcome the problem of limited biodegradability, amino acid units have been successfully 
incorporated into the backbone of poly(ester-amide)s to make it more attractive for enzymatic attack. 
The amino acid based PEAs, originally pioneered by Katsarava et al. [158–160], have however been 
made from naturally occurring amino acid building blocks and appear to be a very attractive new 
family of biodegradable biomaterials. They possess not only good biodegradability, but also good 
mechanical and processing properties, like thermal stability, tensile strength and elastic modulus. The 
biodegradability of different PEAs is one of the properties mostly investigated [161–167]. The 
hydrophobicity of the polymer molecules and their chain flexibility played an important role in the 
enzymatic catalyzed biodegradation of PEAs [163]. The PEAs have been prepared by Int. J. Mol. Sci. 2009, 10                 
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polycondensation of ester-containing diamines with dicarboxylic acids or their derivatives, or by 
ring-opening polymerization of depsipeptides.   
 
Scheme 7. Synthesis of poly(ester amide)s derived from glycine, 1,6-hexanediol(H) and diacid [168]. 
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The amino acids glycine, lysine and phenylalanine were separately copolymerized with AAc and 
1,2-ethanediol to form poly(ester-amide)s of which the two latter were degradable by proteolitic 
enzymes, Similarly, poly(ester-amide)s were derived from 1,6-hexanediol, SA, and any of the amino 
acids alanine, phenylalanine, and glycine [169]. Glycine was also used for the copolymerization with 
1,6-hexanediol and diacids with methylene group numbers ranging from 2 to 8 to prepare a series of 
aliphatic poly(ester-amide)s [92] with low molecular weights that were readily biodegraded by papain 
enzymes. The PEAs derived from glycine was synthesized according to the methodology outlined in 
Scheme 7. 
(2R,3R)-L-tartaric acid (Figure 9) is an attractive monomer with two chiral carbon atoms [170]. Two 
families of PEAs were accordingly prepared from di-o-methyl-L-tartaric acid and succinic acid. The 
first one was synthesized by polycondensation in chloroform of ester trimers of 1,6-hexanediol and 
succinic anhydride with L-tartaric acid and succinic anhydride with L-tartaric acid and 
trimethylsilyl-activated 1,6-hexanediamine, resulting in random copolymers with varying contents of 
ester groups [171]. Hydrophilic and degradable PEAs were obtained. The modulus, strength, Tm, and 
Tg decreases as the content of ester groups increased while the rate of hydrolytic degradation increased. 
Another approach to obtain stereoregular poly(ester-amide)s involved the polycondensation of diacids 
and optically active amino alcohols, such as 2-aminoethanol and leucinol [172].   
 
Figure 9. Structure of L-tartaric acid; (2R,3R)-(+)-2,3-dihydroxybutanedioic acid.   
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A new class of synthetic, biodegradable elastomeric poly(ester amide)s composed of crosslinked 
networks based on the amino alcohol 1,3-diamino-2-hydroxypropane were developed by Bettinger  
et al. [173]. These crosslinked networks feature tensile Young’s modulus on the order of 1 MPa and 
reversable elongations up to 92%. These polymers exhibit in vitro and in vivo biocompatibility. These 
polymers have projected degradation half-lives up to 20 months in vivo. 
The combination of ester and amide linkages in a polymer has been used for the preparation of 
tissue engineering scaffold and polymeric prodrugs. CAMEO® is a poly(ester amide) blend based on 
leucine or phenylalanine that is currently being developed for the site specific delivery of small 
hydrophobic drugs and peptides. Polyesters of malic acid have also been recognized as promising 
prodrug backbones. The pendant carboxylic groups of the poly(malic acid) main chain was covalently 
coupled to the anti-cancer drug adriamycin via amide or ester bonds. The cytotoxic activity of these 
prodrugs was evaluated in vitro [174]. 
 
4. Conclusions 
 
Interest in engineering soft tissues, such as blood vessels, heart valves, nerve, bladder, cartilage, and 
tendons has prompted the development of novel bioelastomers, whose applications require or would 
benefit from the cyclic transfer of mechanical stimuli to cells or tissues. The biodegradable elastomers, 
which are similar to those of native tissue, have been paid more and more attention as the regenerative 
medicine developed. The bioelastomers discussed in this review are likely to become part of the 
available tools that used in tissue engineering to design novel scaffold to accelerate tissue regeneration.   
This review mainly concerns biodegradable bioelastomers prepared by chemical synthesis methods. 
Biocompatible monomers were employed in these studies. The biggest advantage of this type of 
bioelastomers is the performance of materials can be regulated by changing the monomer composition 
and synthesis conditions. The results of all these studies clearly indicate that bioelastomers show 
excellent potential to be developed for a variety of tissue engineering applications. 
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